Victor Montori investigador peruano
Montori, Victor M.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 315209208 (Personal)
Permalink: http://viaf.org/viaf/315209208
Preferred Forms
-
200 _ |
‡a
Montori
‡b
Victor M.
-
100 1 _ ‡a Montori, Victor M.
-
100 1 _ ‡a Montori, Victor M.
-
100 1 _ ‡a Montori, Victor M.
-
100 1 _
‡a
Montori, Victor M.
-
100 1 _ ‡a Montori, Victor M. (sparse)
-
100 1 _
‡a
Montori, Victor M.
-
100 1 _
‡a
Montori, Victor M.
-
100 0 _
‡a
Victor Montori
‡c
investigador peruano
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| Double blind, you are the weakest link--good-bye! |
|
| Endocrinopathy in POEMS syndrome: the Mayo Clinic experience |
|
| Erratum. Aspirin for the Primary Prevention of Cardiovascular Events. A Systematic Review and Meta-Analysis Comparing Patients With and Without Diabetes. Diabetes Care 2009;32:2300-2306. |
|
| Erratum for “A new preference-based analysis for randomized trials can estimate treatment acceptability and effect in complaint patients” [J Clin Epidemiol 59 (2006) 685–696] |
|
| Erratum to: “CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials” [J Clin Epidemiol 2010;63(8):e1–37] |
|
| Estimating risk difference from relative association measures in meta-analysis can infrequently pose interpretational challenges |
|
| Ethical issues in stopping randomized trials early because of apparent benefit. |
|
| Evaluating the structure of the Patient Assessment of Chronic Illness Care (PACIC) survey from the patient's perspective |
|
| Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. |
|
| Evidence-based endocrinology, 2006: |
|
| Evidence-based medicine: application in Alzheimer's disease research |
|
| Evidence-based Practice in Primary Care |
|
| Existing evidence is insufficient to justify metformin or other agents as first-line therapy for type 2 diabetes |
|
| Existing evidence summarization methods cannot guarantee trustworthy patient decision aids |
|
| Exploring differences in the use of the statin choice decision aid and diabetes medication choice decision aid in primary care |
|
| External validation of the Glasgow-Blatchford Bleeding Score and the Rockall Score in the US setting |
|
| External validity, generalisability, applicability and directness: a brief primer |
|
| Factors associated with 30-day readmission rates after percutaneous coronary intervention |
|
| Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions |
|
| Financial conflicts of interest in biomedical research: the need to improve the system |
|
| Fish oil supplementation in type 2 diabetes: a quantitative systematic review |
|
| Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials |
|
| Focusing on the Body of Evidence—Reply |
|
| From artisan to architect: the specialist and systems of provision of diabetes care in 2001. |
|
| Genders of patients and clinicians and their effect on shared decision making: a participant-level meta-analysis |
|
| Getting on the same page: Communication, patient involvement and shared understanding of "decisions" in oncology |
|
| Glucose control in older adults with diabetes mellitus--more harm than good? |
|
| Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis |
|
| GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes |
|
| GRADE guidelines: 9. Rating up the quality of evidence |
|
| Grading quality of evidence and strength of recommendations for diagnostic tests and strategies |
|
| Guideline: In type 2 diabetes, ACP recommends metformin monotherapy if drugs are needed for glycemic control |
|
| Guideline methodology of the Society for Vascular Surgery including the experience with the GRADE framework |
|
| Guidelines for Cardiovascular Risk Assessment and Cholesterol Treatment—Reply |
|
| Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic |
|
| HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: observational population based study |
|
| Helping patients make sense of the risks of taking GLP-1 agonists |
|
| Helping Patients With Type 2 Diabetes Mellitus Make Treatment Decisions |
|
| Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes |
|
| How should clinicians and patients choose antihyperglycemic agents? : an evidence-based approach |
|
| How should the impact of different presentations of treatment effects on patient choice be evaluated? A pilot randomized trial |
|
| How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature |
|
| How to teach evidence-based medicine to teachers: reflections from a workshop experience |
|
| Humanistic communication in the evaluation of shared decision making: A systematic review |
|
| Humor During Clinical Practice: Analysis of Recorded Clinical Encounters. |
|
| Hyperglycemia in acutely ill patients |
|
| Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists |
|
| Hypoglycemia as an indicator of good diabetes care. |
|
| Identification of tachypnea and subcostal retractions as clinical signs for the diagnosis of community-acquired pneumonia among children: systematic review and meta-analysis |
|
| Identifying treatment burden as an important concept for end of life care in those with advanced heart failure |
|
| Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials |
|
| Impact of a Shared Decision Making Intervention on Health Care Utilization: A Secondary Analysis of the Chest Pain Choice Multicenter Randomized Trial |
|
| Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial |
|
| Impact of decision aids used during clinical encounters on clinician outcomes and consultation length: a systematic review |
|
| Impact of sociodemographic patient characteristics on the efficacy of decision AIDS: a patient-level meta-analysis of 7 randomized trials |
|
| An Informatics Approach to Implement Support for Shared Decision Making for Primary Prevention Statin Therapy |
|
| Jak lekarze i pacjenci powinni wybierać leki przeciwcukrzycowe? : podejście oparte na danych naukowych |
|
| Minimally disruptive medicine and its implications for improving patient adherence, 2015: |
|
| An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. |
|
| A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease |
|
| Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk? |
|
| Should we use intensive hypoglycemic treatment in patients with advanced type 2 diabetes? |
|
| A survey evaluating surgeons' peri-operative usage of acetyl-salicylic acid (ASA) and their willingness to enroll their patients in a perioperative ASA randomized controlled trial |
|
| A systematic review for the screening for peripheral arterial disease in asymptomatic patients |
|
| A systematic review of lower extremity arterial revascularization economic analyses |
|
| A systematic review of patient-reported measures of burden of treatment in three chronic diseases |
|
| A systematic review of treatment of intermittent claudication in the lower extremities |
|
| A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial |
|
| Why we revolt : a patient revolution for careful and kind care |
|
